MedTrace Logo

Trifluridin/tipirACil in MeTastatIc Colorectal Cancer

NCT03665506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 315

Last updated 2024-12-03

No results posted yet for this study

Summary

A non-interventional, prospective, open, multicenter study in Germany in patients with metastatic colorectal cancer who have been previously treated with, or are not considered candidates for, available therapies and with decision for treatment with trifluridin/tipiracil.

Conditions

Interventions

DRUG

Trifluridin/Tipiracil

QoL assessment

Sponsors & Collaborators

  • iOMEDICO AG

    collaborator INDUSTRY

  • Servier

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-25
Primary Completion
2021-08-02
Completion
2021-08-02

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03665506 on ClinicalTrials.gov